2/24
11:31 am
mygn
Why Myriad Genetics (MYGN) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Myriad Genetics (MYGN) Stock Is Trading Up Today [Yahoo! Finance]
2/24
10:18 am
mygn
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Wells Fargo & Company from $6.50 to $6.00. They now have an "equal weight" rating on the stock.
Medium
Report
Myriad Genetics (NASDAQ:MYGN) had its price target lowered by analysts at Wells Fargo & Company from $6.50 to $6.00. They now have an "equal weight" rating on the stock.
2/24
09:03 am
mygn
Myriad Genetics (NASDAQ:MYGN) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
High
Report
Myriad Genetics (NASDAQ:MYGN) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/24
09:00 am
mygn
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
High
Report
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
2/24
12:21 am
mygn
Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
High
Report
Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ... [Yahoo! Finance]
2/23
04:31 pm
mygn
Myriad Genetics's (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22% [Yahoo! Finance]
High
Report
Myriad Genetics's (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22% [Yahoo! Finance]
2/23
04:05 pm
mygn
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
Low
Report
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
2/19
09:15 am
mygn
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
Low
Report
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
2/16
04:41 pm
mygn
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 [Yahoo! Finance]
Low
Report
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026 [Yahoo! Finance]
2/16
04:15 pm
mygn
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
Low
Report
Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
1/27
08:50 am
mygn
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Low
Report
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
1/22
04:00 am
mygn
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm [Yahoo! Finance]
Medium
Report
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm [Yahoo! Finance]
1/21
06:20 am
mygn
Myriad Genetics (NASDAQ:MYGN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Myriad Genetics (NASDAQ:MYGN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/12
09:11 am
mygn
Myriad Genetics Q4 and 2025 revenue ranges include consensus [Seeking Alpha]
Medium
Report
Myriad Genetics Q4 and 2025 revenue ranges include consensus [Seeking Alpha]
1/12
08:30 am
mygn
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
Low
Report
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
1/10
07:02 pm
mygn
What Analysts Think Is Shaping The Story For Myriad Genetics (MYGN) Now [Yahoo! Finance]
Low
Report
What Analysts Think Is Shaping The Story For Myriad Genetics (MYGN) Now [Yahoo! Finance]
1/5
05:07 pm
mygn
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
04:15 pm
mygn
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
12/25
07:00 pm
mygn
Looking at the Narrative for Myriad Genetics After Price Target Revisions and Growth Concerns [Yahoo! Finance]
Low
Report
Looking at the Narrative for Myriad Genetics After Price Target Revisions and Growth Concerns [Yahoo! Finance]
12/22
03:27 pm
mygn
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why [Yahoo! Finance]
Low
Report
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why [Yahoo! Finance]
12/9
09:00 am
mygn
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
Medium
Report
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
12/1
12:48 pm
mygn
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today [Yahoo! Finance]
Low
Report
Why Myriad Genetics (MYGN) Stock Is Trading Lower Today [Yahoo! Finance]